首页> Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology> Association between Concomitant Use of Hydrochlorothiazide and Adverse Chemotherapy-Related Events among Older Women with Breast Cancer Treated with Cyclophosphamide.

Association between Concomitant Use of Hydrochlorothiazide and Adverse Chemotherapy-Related Events among Older Women with Breast Cancer Treated with Cyclophosphamide.

导出 OA

翻译打印收藏纠错

第一作者： Christine D,Hsu

第一单位： Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

作者： Christine D,Hsu ^[1] ; Sharon Peacock,Hinton ^[1] ; Katherine E,Reeder-Hayes ^[2] ; Hanna K,Sanoff ^[2] ; Jennifer L,Lund ^[3]

作者单位： Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. ^[1] Division of Hematology/Oncology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. ^[2] Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. jennifer.lund@unc.edu.;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. ^[3]

医学主题词老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);环磷酰胺(Cyclophosphamide);药物相互作用(Drug Interactions);女(雌)性(Female);住院(Hospitalization);人类(Humans);氢氯噻嗪(Hydrochlorothiazide);乳房切除术(Mastectomy);Medicare(Medicare);中性粒细胞减少(Neutropenia);SEER规划(SEER Program);治疗结果(Treatment Outcome);美国(United States)

DOI 10.1158/1055-9965.EPI-19-1079

PMID 31871107

发布时间 2025-05-30

基金项目

K12 CA120780/CA/NCI NIH HHS/United States UL1 TR001111/TR/NCATS NIH HHS/United States HHSN261201000140C/CA/NCI NIH HHS/United States HHSN261201000035C/CA/NCI NIH HHS/United States UL1 TR002489/TR/NCATS NIH HHS/United States HHSN261201000035I/CA/NCI NIH HHS/United States HHSN261201000034C/CA/NCI NIH HHS/United States U58 DP003862/DP/NCCDPHP CDC HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交